Blood markers for placenta accreta in placenta previa
Part of Women’s health & pregnancy clinical trials.
This study looks at blood tests to predict if the placenta is too attached to the womb in women with placenta previa. The goal is to help plan safer deliveries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You have placenta previa, diagnosed by ultrasound.
- You are pregnant with one baby.
- You are at least 28 weeks pregnant.
- You have had a cesarean section before.
- Your condition is stable on admission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how deeply the placenta attaches to the womb in women with a condition called placenta accreta. It aims to better understand the condition to improve care and outcomes.
This study tests a new ultrasound measurement to predict how deeply the placenta attaches to the uterus in women with placenta previa and a history of C-sections. It may help doctors prepare for delivery and reduce risks.
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
This study tests a new artificial-intelligence tool that analyzes ultrasound images to detect placenta accreta spectrum—a condition where the placenta attaches too deeply to the uterus. If you're pregnant with risk factors like placenta previa (placenta covering the cervix), this trial may help doctors catch the problem earlier.
This trial tests whether placing a small balloon in a major blood vessel during a planned c-section can help reduce heavy bleeding in women with placenta accreta spectrum. If effective, it could make surgery safer and reduce the need for blood transfusions.
This trial studies what happens after a planned C-section when placenta accreta spectrum is diagnosed by ultrasound and the uterus is kept. It may help doctors understand the safest way to manage this condition and what outcomes to expect.
Hear when a new Placenta Accreta Spectrum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.